What's the year keytruda was given the green light by the fda for cancer care?

2014.

Keytruda (pembrolizumab) received its first FDA approval in 2014 for metastatic or unresectable melanoma, and has since been approved for many other cancer types as part of its expanding role in cancer care. If you’d like, I can list some of the major later indications.